» Articles » PMID: 31305416

Sentinel Lymph Node Mapping Procedure in T1 Colorectal Cancer: A Systematic Review of Published Studies

Overview
Specialty General Medicine
Date 2019 Jul 16
PMID 31305416
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: to investigate the role of sentinel lymph node mapping procedure in T1 Colorectal cancer.

Background: The incidence of T1 Colorectal cancer is increasing thanks to screening and awareness campaigns. The issue concerning T1 is when to consider a local treatment curative or when it is necessary a radical resection. The histopathological features of resected polyps are able to predict the nodal spread but the value of specificity is increasingly a problem of these predictors. The sentinel lymph node procedure could be a solution.

Methods: A systematic review was performed following PRISMA guidelines and using "sentinel node", "lymph nodes", and "colorectal cancer" as search terms in PubMed and Embase databases. References from included studies, review articles, and editorials were cross-checked. The risk of bias and quality of the included studies were assessed using the QUADAS-2 tool. The primary outcome was sentinel lymph node accuracy rate and the secondary outcome was sentinel lymph node detection rate for T1 Colorectal cancer.

Results: A total of 12 studies (108 patients) met inclusion and exclusion criteria, 8 were monocentric cohort studies and 4 were multicentric cohort studies. The rate of sentinel lymph node accuracy in T1 colorectal cancer varies from 89% to 100%. Only 1 false negative was found. In 7 of these 12 studies (71 patients) the detection rate of T1 colorectal cancer was reported and showed a variation from 92% to 100%. Even in this case, only 1 case of failed procedure was found.

Discussion: The literature on this topic agrees on that sentinel lymph node mapping, differently from breast cancer and melanomas should not be used for therapeutic purposes in colorectal cancer, but mainly to refine staging. The reason is the low sensitivity of this procedure with an accompanying high false negative rate. However, the data refers mainly to advanced stages of the disease because there are few data available on the earlier stages and in particular related to T1. Isolating the data related only to T1, the false negative rate seems to be very low. Additional studies are necessary, but a decisional role of sentinel lymph node mapping on the treatment of T1 Colorectal cancer is possible in the future.

Citing Articles

Factors Affecting the Efficiency of Near-Infrared Indocyanine Green (NIR/ICG) in Lymphatic Mapping for Colorectal Cancer: A Systematic Review.

Shevchenko I, Serban D, Dascalu A, Tribus L, Alius C, Cristea B Cureus. 2024; 16(2):e55290.

PMID: 38558607 PMC: 10981778. DOI: 10.7759/cureus.55290.


Indocyanine green dye and its application in gastrointestinal surgery: The future is bright green.

Lim Z, Mohan S, Balasubramaniam S, Ahmed S, Siew C, Shelat V World J Gastrointest Surg. 2023; 15(9):1841-1857.

PMID: 37901741 PMC: 10600780. DOI: 10.4240/wjgs.v15.i9.1841.


Role of methylene blue in detecting the sentinel lymph node in colorectal cancer: vs. technique.

Staniloaie D, Budin C, Vasile D, Iancu G, Ilco A, Voiculescu D Exp Ther Med. 2021; 23(1):72.

PMID: 34934443 PMC: 8649879. DOI: 10.3892/etm.2021.10995.

References
1.
Gonzalez A . Sentinel Lymph Node Biopsy: Past and Present Implications for the Management of Cutaneous Melanoma with Nodal Metastasis. Am J Clin Dermatol. 2018; 19(Suppl 1):24-30. PMC: 6244615. DOI: 10.1007/s40257-018-0379-0. View

2.
Sommariva A, Donisi P, Gnocato B, Vianello R, Stracca Pansa V, Zaninotto G . Factors affecting false-negative rates on ex vivo sentinel lymph node mapping in colorectal cancer. Eur J Surg Oncol. 2009; 36(2):130-4. DOI: 10.1016/j.ejso.2009.06.007. View

3.
Whiting P, Rutjes A, Westwood M, Mallett S, Deeks J, Reitsma J . QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155(8):529-36. DOI: 10.7326/0003-4819-155-8-201110180-00009. View

4.
Viehl C, Guller U, Langer I, Laffer U, Oertli D, Zuber M . Factors influencing the success of in vivo sentinel lymph node procedure in colon cancer patients: Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. World J Surg. 2013; 37(4):873-7. DOI: 10.1007/s00268-013-1910-3. View

5.
Cahill R, Perretta S, Leroy J, Dallemagne B, Marescaux J . Lymphatic mapping and sentinel node biopsy in the colonic mesentery by Natural Orifice Transluminal Endoscopic Surgery (NOTES). Ann Surg Oncol. 2008; 15(10):2677-83. DOI: 10.1245/s10434-008-9952-8. View